[en] Objectives: Non-adherence to asthma medication can lead to lower disease control and asthma exacerbations that may be fatal. This survey assessed the attitude and expectations of Belgian asthma patients towards their treatment.Methods: This cross-sectional survey was conducted between June 2015 and February 2016 in 70 Belgian pharmacies. Participants completing the survey had to be ≥15 years, diagnosed with asthma, and on inhaled corticosteroid-based treatment. The analysis included 80 completed questionnaires.Results: Participants comprehended well that controller drugs are intended to prevent the occurrence of asthma symptoms and complications, and their long-term daily use should be maintained. Twenty seven percent of participants indicated fear of side effects concerning long-term daily use of a controller inhaler. Participants had a good understanding that quick-relief drugs are intended to (quickly) relieve asthma symptoms and do not need to be used on a systematic, daily basis. Out of 73 participants on long-term controller drugs, 33 (45%) were 'non-adherent' (used less frequently than prescribed). Suboptimal adherence to maintenance treatment appeared to increase nightly awakenings and the risk of restrictions in activities due to asthma. Out of 54 participants with available quick-relief drug adherence data, 18 (33%) were non-adherent (used their quick-relief drug more frequently than prescribed).Discussion: This survey confirms suboptimal adherence to maintenance controller therapy and overuse of short-acting reliever medications among Belgian patients, which affects asthma control and quality of life. A substantial proportion of patients expressed fear about their chronic therapy, indicating the need for patient education about their disease and its management.
Disciplines :
General & internal medicine
Author, co-author :
Dupont, Lieven; Department of Respiratory Medicine, University Hospital Gasthuisberg, Leuven, Belgium
Pilette, Charles; Department of Pulmonary Medicine, Cliniques universitaires St Luc, and Institute of Experimental and Clinical Research, Université Catholique de Louvain, Brussels, Belgium
Schleich, FLorence ; Centre Hospitalier Universitaire de Liège - CHU > > Service de pneumologie - allergologie
Joos, Guy; Department of Respiratory Medicine, Ghent University Hospital, Gent, Belgium
Language :
English
Title :
Health literacy among asthma patients and treatment expectations: results of a Belgian survey.
Masoli M, Fabian D, Holt S, et al. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy. 2004;59(5):469–478.
Lundback B, Backman H, Lotvall J, et al. Is asthma prevalence still increasing? Expert Rev Respir Med. 2016;10(1):39–51.
Ducharme FM, Lasserson TJ, Cates CJ., Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma. Cochrane Database Syst Rev. 2011;(5):CD003137.
Suissa S, Ernst P. Inhaled corticosteroids: impact on asthma morbidity and mortality. J Allergy Clin Immunol. 2001;107(6):937–944.
Suissa S, Ernst P, Benayoun S, et al. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med. 2000;343(5):332–336.
Global Initiative for Asthma. Global strategy for asthma management and prevention. 2018. Available from: www.ginasthma.org.
Menckeberg TT, Bouvy ML, Bracke M, et al. Beliefs about medicines predict refill adherence to inhaled corticosteroids. J Psychosom Res. 2008;64(1):47–54.
Williams LK, Pladevall M, Xi H, et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol. 2004;114(6):1288–1293.
Bender B. Physician-patient communication as a tool that can change adherence. Ann Allergy Asthma Immunol. 2009;103(1):1–2.
Clyne W, White S, McLachlan S. Developing consensus-based policy solutions for medicines adherence for Europe: a Delphi study. BMC Health Serv Res. 2012;12:425.
Blaiss MS, Kaliner MA, Baena-Cagnani CE, et al. Barriers to asthma treatment in the United States: results from the global asthma physician and patient survey. World Allergy Organ J. 2009;2(12):303–313.
Laforest L, El Hasnaoui A, Pribil C, et al. Asthma patients’ self-reported behaviours toward inhaled corticosteroids. Respir Med. 2009;103(9):1366–1375.
Panettieri Jr.RA, Spector SL, Tringale M, et al. Patients’ and primary care physicians’ beliefs about asthma control and risk. Allergy Asthma Proc. 2009;30(5):519–528.
Bourdin A, Halimi L, Vachier I, et al. Adherence in severe asthma. Clin Exp Allergy. 2012;42(11):1566–1574.
Gamble J, Stevenson M, McClean E, et al. The prevalence of nonadherence in difficult asthma. Am J Respir Crit Care Med. 2009;180(9):817–822.
Ahmad A, Sorensen K. Enabling and hindering factors influencing adherence to asthma treatment among adolescents: a systematic literature review. J Asthma. 2016;53(8):862–878.
Van ganse E, Leufkens HG, Vincken W, et al. Assessing asthma management from interviews of patients and family physicians. J Asthma. 1997;34(3):203–209.
Braido F, Baiardini I, Sumberesi M, et al. Obstructive lung diseases and inhaler treatment: results from a national public pragmatic survey. Respir Res. 2013;14:94.
Lindberg M, Ekstrom T, Moller M, et al. Asthma care and factors affecting medication compliance: the patient’s point of view. Int J Qual Health Care. 2001;13(5):375–383.
Partridge MR, Dal Negro RW, Olivieri D. Understanding patients with asthma and COPD: insights from a European study. Primary Care Respir J. 2011;20(3): 315–323, 317 p following 323.
Foster JM, Smith L, Bosnic-Anticevich SZ, et al. Identifying patient-specific beliefs and behaviours for conversations about adherence in asthma. Intern Med J. 2012;42(6):e136–144.
Maspero JF, Jardim JR, Aranda A, et al. Insights, attitudes, and perceptions about asthma and its treatment: findings from a multinational survey of patients from Latin America. World Allergy Organ J. 2013;6(1):19.
Thompson PJ, Salvi S, Lin J, et al. Insights, attitudes and perceptions about asthma and its treatment: findings from a multinational survey of patients from 8 Asia-Pacific countries and Hong Kong. Respirology. 2013;18(6):957–967.
Ponieman D, Wisnivesky JP, Leventhal H, et al. Impact of positive and negative beliefs about inhaled corticosteroids on adherence in inner-city asthmatic patients. Ann Allergy Asthma Immunol. 2009;103(1):38–42.
Brandt S, Dickinson B. Time and risk preferences and the use of asthma controller medication. Pediatrics. 2013;131(4):e1204–1210.
Partridge MR, van der Molen T, Myrseth SE, et al. Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med. 2006;6:13.
Perpina Tordera M, Martinez Moragon E, Belloch Fuster A, et al. Spanish asthma patients’ beliefs about health and medicines: validation of 2 questionnaires. Arch Bronconeumol. 2009;45(5):218–223.